1,724
Views
18
CrossRef citations to date
0
Altmetric
Research Paper

Human factors and pathways essential for mediating epigenetic gene silencing

, , , , , , , , , & show all
Pages 1280-1289 | Received 30 May 2014, Accepted 21 Jul 2014, Published online: 04 Aug 2014

References

  • Holliday R. Epigenetics: a historical overview. Epigenetics 2006; 1:76 - 80; http://dx.doi.org/10.4161/epi.1.2.2762; PMID: 17998809
  • Meissner A. Epigenetic modifications in pluripotent and differentiated cells. Nat Biotechnol 2010; 28:1079 - 88; http://dx.doi.org/10.1038/nbt.1684; PMID: 20944600
  • Smith ZD, Meissner A. DNA methylation: roles in mammalian development. Nat Rev Genet 2013; 14:204 - 20; http://dx.doi.org/10.1038/nrg3354; PMID: 23400093
  • Berger SL, Kouzarides T, Shiekhattar R, Shilatifard A. An operational definition of epigenetics. Genes Dev 2009; 23:781 - 3; http://dx.doi.org/10.1101/gad.1787609; PMID: 19339683
  • Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res 2011; 21:381 - 95; http://dx.doi.org/10.1038/cr.2011.22; PMID: 21321607
  • Klose RJ, Bird AP. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 2006; 31:89 - 97; http://dx.doi.org/10.1016/j.tibs.2005.12.008; PMID: 16403636
  • Kohli RM, Zhang Y. TET enzymes, TDG and the dynamics of DNA demethylation. Nature 2013; 502:472 - 9; http://dx.doi.org/10.1038/nature12750; PMID: 24153300
  • Rothbart SB, Strahl BD. Interpreting the language of histone and DNA modifications. Biochim Biophys Acta 2014; 1839:627 - 43; http://dx.doi.org/10.1016/j.bbagrm.2014.03.001; PMID: 24631868
  • Bonasio R, Tu S, Reinberg D. Molecular signals of epigenetic states. Science 2010; 330:612 - 6; http://dx.doi.org/10.1126/science.1191078; PMID: 21030644
  • Probst AV, Dunleavy E, Almouzni G. Epigenetic inheritance during the cell cycle. Nat Rev Mol Cell Biol 2009; 10:192 - 206; http://dx.doi.org/10.1038/nrm2640; PMID: 19234478
  • Bickmore WA, van Steensel B. Genome architecture: domain organization of interphase chromosomes. Cell 2013; 152:1270 - 84; http://dx.doi.org/10.1016/j.cell.2013.02.001; PMID: 23498936
  • Collas P, Lund EG, Oldenburg AR. Closing the (nuclear) envelope on the genome: how nuclear lamins interact with promoters and modulate gene expression. Bioessays 2014; 36:75 - 83; http://dx.doi.org/10.1002/bies.201300138; PMID: 24272858
  • Berger SL. The complex language of chromatin regulation during transcription. Nature 2007; 447:407 - 12; http://dx.doi.org/10.1038/nature05915; PMID: 17522673
  • Cedar H, Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 2009; 10:295 - 304; http://dx.doi.org/10.1038/nrg2540; PMID: 19308066
  • Ernst J, Kellis M. Discovery and characterization of chromatin states for systematic annotation of the human genome. Nat Biotechnol 2010; 28:817 - 25; http://dx.doi.org/10.1038/nbt.1662; PMID: 20657582
  • Gardner KE, Allis CD, Strahl BD. Operating on chromatin, a colorful language where context matters. J Mol Biol 2011; 409:36 - 46; http://dx.doi.org/10.1016/j.jmb.2011.01.040; PMID: 21272588
  • Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007; 128:683 - 92; http://dx.doi.org/10.1016/j.cell.2007.01.029; PMID: 17320506
  • Taby R, Issa JP. Cancer epigenetics. CA Cancer J Clin 2010; 60:376 - 92; http://dx.doi.org/10.3322/caac.20085; PMID: 20959400
  • Boumber Y, Issa JP. Epigenetics in cancer: what’s the future?. Oncology (Williston Park) 2011; 25:220 - 6, 228; PMID: 21548464
  • Marks PA. The clinical development of histone deacetylase inhibitors as targeted anticancer drugs. Expert Opin Investig Drugs 2010; 19:1049 - 66; http://dx.doi.org/10.1517/13543784.2010.510514; PMID: 20687783
  • Santos FP, Kantarjian H, Garcia-Manero G, Issa JP, Ravandi F. Decitabine in the treatment of myelodysplastic syndromes. Expert Rev Anticancer Ther 2010; 10:9 - 22; http://dx.doi.org/10.1016/j.stem.2009.03.005; PMID: 19341620
  • Feng B, Ng JH, Heng JC, Ng HH. Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. Cell Stem Cell 2009; 4:301 - 12; http://dx.doi.org/10.1016/j.stem.2009.03.005; PMID: 19341620
  • Poleshko A, Einarson MB, Shalginskikh N, Zhang R, Adams PD, Skalka AM, Katz RA. Identification of a functional network of human epigenetic silencing factors. J Biol Chem 2010; 285:422 - 33; http://dx.doi.org/10.1074/jbc.M109.064667; PMID: 19880521
  • Tsui M, Xie T, Orth JD, Carpenter AE, Rudnicki S, Kim S, Shamu CE, Mitchison TJ. An intermittent live cell imaging screen for siRNA enhancers and suppressors of a kinesin-5 inhibitor. PLoS One 2009; 4:e7339; http://dx.doi.org/10.1371/journal.pone.0007339; PMID: 19802393
  • Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C, et al. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res 2013; 41:D808 - 15; http://dx.doi.org/10.1093/nar/gks1094; PMID: 23203871
  • Meulmeester E, Melchior F. Cell biology: SUMO. Nature 2008; 452:709 - 11; http://dx.doi.org/10.1038/452709a; PMID: 18401402
  • Wilkinson KA, Henley JM. Mechanisms, regulation and consequences of protein SUMOylation. Biochem J 2010; 428:133 - 45; http://dx.doi.org/10.1042/BJ20100158; PMID: 20462400
  • Sarraf SA, Stancheva I. Methyl-CpG binding protein MBD1 couples histone H3 methylation at lysine 9 by SETDB1 to DNA replication and chromatin assembly. Mol Cell 2004; 15:595 - 605; http://dx.doi.org/10.1016/j.molcel.2004.06.043; PMID: 15327775
  • Raynal NJ, Si J, Taby RF, Gharibyan V, Ahmed S, Jelinek J, Estécio MR, Issa JP. DNA methylation does not stably lock gene expression but instead serves as a molecular mark for gene silencing memory. Cancer Res 2012; 72:1170 - 81; http://dx.doi.org/10.1158/0008-5472.CAN-11-3248; PMID: 22219169
  • Si J, Boumber YA, Shu J, Qin T, Ahmed S, He R, Jelinek J, Issa JP. Chromatin remodeling is required for gene reactivation after decitabine-mediated DNA hypomethylation. Cancer Res 2010; 70:6968 - 77; http://dx.doi.org/10.1158/0008-5472.CAN-09-4474; PMID: 20713525
  • Schultz DC, Ayyanathan K, Negorev D, Maul GG, Rauscher FJ 3rd. SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins. Genes Dev 2002; 16:919 - 32; http://dx.doi.org/10.1101/gad.973302; PMID: 11959841
  • Segré CV, Chiocca S. Regulating the regulators: the post-translational code of class I HDAC1 and HDAC2. J Biomed Biotechnol 2011; 2011:690848; http://dx.doi.org/10.1155/2011/690848; PMID: 21197454
  • Seward DJ, Cubberley G, Kim S, Schonewald M, Zhang L, Tripet B, Bentley DL. Demethylation of trimethylated histone H3 Lys4 in vivo by JARID1 JmjC proteins. Nat Struct Mol Biol 2007; 14:240 - 2; http://dx.doi.org/10.1038/nsmb1200; PMID: 17310255
  • Girdwood D, Bumpass D, Vaughan OA, Thain A, Anderson LA, Snowden AW, Garcia-Wilson E, Perkins ND, Hay RT. P300 transcriptional repression is mediated by SUMO modification. Mol Cell 2003; 11:1043 - 54; http://dx.doi.org/10.1016/S1097-2765(03)00141-2; PMID: 12718889
  • Ashburner BP, Westerheide SD, Baldwin AS Jr.. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol 2001; 21:7065 - 77; http://dx.doi.org/10.1128/MCB.21.20.7065-7077.2001; PMID: 11564889
  • Zhang Y, Iratni R, Erdjument-Bromage H, Tempst P, Reinberg D. Histone deacetylases and SAP18, a novel polypeptide, are components of a human Sin3 complex. Cell 1997; 89:357 - 64; http://dx.doi.org/10.1016/S0092-8674(00)80216-0; PMID: 9150135
  • Matyash A, Singh N, Hanes SD, Urlaub H, Jäckle H. SAP18 promotes Krüppel-dependent transcriptional repression by enhancer-specific histone deacetylation. J Biol Chem 2009; 284:3012 - 20; http://dx.doi.org/10.1074/jbc.M806163200; PMID: 19049982
  • Zullo JM, Demarco IA, Piqué-Regi R, Gaffney DJ, Epstein CB, Spooner CJ, Luperchio TR, Bernstein BE, Pritchard JK, Reddy KL, et al. DNA sequence-dependent compartmentalization and silencing of chromatin at the nuclear lamina. Cell 2012; 149:1474 - 87; http://dx.doi.org/10.1016/j.cell.2012.04.035; PMID: 22726435
  • David G, Neptune MA, DePinho RA. SUMO-1 modification of histone deacetylase 1 (HDAC1) modulates its biological activities. J Biol Chem 2002; 277:23658 - 63; http://dx.doi.org/10.1074/jbc.M203690200; PMID: 11960997
  • Ribet D, Hamon M, Gouin E, Nahori MA, Impens F, Neyret-Kahn H, Gevaert K, Vandekerckhove J, Dejean A, Cossart P. Listeria monocytogenes impairs SUMOylation for efficient infection. Nature 2010; 464:1192 - 5; http://dx.doi.org/10.1038/nature08963; PMID: 20414307
  • Fujita N, Watanabe S, Ichimura T, Tsuruzoe S, Shinkai Y, Tachibana M, Chiba T, Nakao M. Methyl-CpG binding domain 1 (MBD1) interacts with the Suv39h1-HP1 heterochromatic complex for DNA methylation-based transcriptional repression. J Biol Chem 2003; 278:24132 - 8; http://dx.doi.org/10.1074/jbc.M302283200; PMID: 12711603
  • Uchimura Y, Ichimura T, Uwada J, Tachibana T, Sugahara S, Nakao M, Saitoh H. Involvement of SUMO modification in MBD1- and MCAF1-mediated heterochromatin formation. J Biol Chem 2006; 281:23180 - 90; http://dx.doi.org/10.1074/jbc.M602280200; PMID: 16757475
  • Ichimura T, Watanabe S, Sakamoto Y, Aoto T, Fujita N, Nakao M. Transcriptional repression and heterochromatin formation by MBD1 and MCAF/AM family proteins. J Biol Chem 2005; 280:13928 - 35; http://dx.doi.org/10.1074/jbc.M413654200; PMID: 15691849
  • Nathan D, Ingvarsdottir K, Sterner DE, Bylebyl GR, Dokmanovic M, Dorsey JA, Whelan KA, Krsmanovic M, Lane WS, Meluh PB, et al. Histone sumoylation is a negative regulator in Saccharomyces cerevisiae and shows dynamic interplay with positive-acting histone modifications. Genes Dev 2006; 20:966 - 76; http://dx.doi.org/10.1101/gad.1404206; PMID: 16598039
  • Shiio Y, Eisenman RN. Histone sumoylation is associated with transcriptional repression. Proc Natl Acad Sci U S A 2003; 100:13225 - 30; http://dx.doi.org/10.1073/pnas.1735528100; PMID: 14578449
  • Nagpal K, Watanabe KS, Tsao BP, Tsokos GC. Ikaros represses protein phosphatase 2A (PP2A) expression through an intronic binding site. J Biol Chem 2014; In press http://dx.doi.org/10.1074/jbc.M114.558197; PMID: 24692537
  • Mullighan CG, Su X, Zhang J, Radtke I, Phillips LA, Miller CB, Ma J, Liu W, Cheng C, Schulman BA, et al, Children’s Oncology Group. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med 2009; 360:470 - 80; http://dx.doi.org/10.1056/NEJMoa0808253; PMID: 19129520
  • Peterson EA, Petty EM. Conquering the complex world of human septins: implications for health and disease. Clin Genet 2010; 77:511 - 24; http://dx.doi.org/10.1111/j.1399-0004.2010.01392.x; PMID: 20236126
  • Cerveira N, Bizarro S, Teixeira MR. MLL-SEPTIN gene fusions in hematological malignancies. Biol Chem 2011; 392:713 - 24; http://dx.doi.org/10.1515/BC.2011.072; PMID: 21714766
  • Cervoni N, Detich N, Seo SB, Chakravarti D, Szyf M. The oncoprotein Set/TAF-1beta, an inhibitor of histone acetyltransferase, inhibits active demethylation of DNA, integrating DNA methylation and transcriptional silencing. J Biol Chem 2002; 277:25026 - 31; http://dx.doi.org/10.1074/jbc.M202256200; PMID: 11978794
  • Quentmeier H, Schneider B, Röhrs S, Romani J, Zaborski M, Macleod RA, Drexler HG. SET-NUP214 fusion in acute myeloid leukemia- and T-cell acute lymphoblastic leukemia-derived cell lines. J Hematol Oncol 2009; 2:3; http://dx.doi.org/10.1186/1756-8722-2-3; PMID: 19166587
  • Isermann P, Lammerding J. Nuclear mechanics and mechanotransduction in health and disease. Curr Biol 2013; 23:R1113 - 21; http://dx.doi.org/10.1016/j.cub.2013.11.009; PMID: 24355792
  • Winograd-Katz SE, Fässler R, Geiger B, Legate KR. The integrin adhesome: from genes and proteins to human disease. Nat Rev Mol Cell Biol 2014; 15:273 - 88; http://dx.doi.org/10.1038/nrm3769; PMID: 24651544
  • Mehta AK, Majumdar SS, Alam P, Gulati N, Brahmachari V. Epigenetic regulation of cytomegalovirus major immediate-early promoter activity in transgenic mice. Gene 2009; 428:20 - 4; http://dx.doi.org/10.1016/j.gene.2008.09.033; PMID: 18976699
  • Poleshko A, Shalginskikh N, Katz RA. Identification of epigenetic silencing factors by siRNA screening. In Epigenomics: From Chromatin Biology to Therapeutics, edited by K. Appasani (Cambridge University Press, New York, 2012), Chap. 3.
  • Poleshko A, Mansfield KM, Burlingame CC, Andrake MD, Shah NR, Katz RA. The human protein PRR14 tethers heterochromatin to the nuclear lamina during interphase and mitotic exit. Cell Rep 2013; 5:292 - 301; http://dx.doi.org/10.1016/j.celrep.2013.09.024; PMID: 24209742
  • Reddy KL, Zullo JM, Bertolino E, Singh H. Transcriptional repression mediated by repositioning of genes to the nuclear lamina. Nature 2008; 452:243 - 7; http://dx.doi.org/10.1038/nature06727; PMID: 18272965
  • Shevelyov YY, Nurminsky DI. The nuclear lamina as a gene-silencing hub. Curr Issues Mol Biol 2012; 14:27 - 38; PMID: 21795760
  • Poleshko A, Katz RA. Specifying peripheral heterochromatin during nuclear lamina reassembly. Nucleus 2014; 5:32 - 9; http://dx.doi.org/10.4161/nucl.28167; PMID: 24637393
  • Poleshko A, Palagin I, Zhang R, Boimel P, Castagna C, Adams PD, Skalka AM, Katz RA. Identification of cellular proteins that maintain retroviral epigenetic silencing: evidence for an antiviral response. J Virol 2008; 82:2313 - 23; http://dx.doi.org/10.1128/JVI.01882-07; PMID: 18094192
  • Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4:44 - 57; http://dx.doi.org/10.1038/nprot.2008.211; PMID: 19131956
  • Morin R, Bainbridge M, Fejes A, Hirst M, Krzywinski M, Pugh T, McDonald H, Varhol R, Jones S, Marra M. Profiling the HeLa S3 transcriptome using randomly primed cDNA and massively parallel short-read sequencing. Biotechniques 2008; 45:81 - 94; http://dx.doi.org/10.2144/000112900; PMID: 18611170
  • Zhang Z, Meng T, He J, Li M, Tong LJ, Xiong B, Lin L, Shen J, Miao ZH, Ding J. MT7, a novel compound from a combinatorial library, arrests mitosis via inhibiting the polymerization of microtubules. Invest New Drugs 2010; 28:715 - 28; http://dx.doi.org/10.1007/s10637-009-9303-z; PMID: 19705064